Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$12,968,548
-$698,213 QoQ
Shares Held
102,648
+4.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#390
of 2,266 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $567,998,433 across 14 Drug Manufacturers - General names. GILD ranks #9 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
118,181 | $141,749,848 | |
| 2 | JNJ |
Johnson & Johnson
|
456,860 | $116,028,734 | |
| 3 | ABBV |
AbbVie Inc.
|
426,678 | $107,369,251 | |
| 4 | PFE |
Pfizer Inc
|
1,884,553 | $45,380,036 | |
| 5 | MRK |
Merck & Co., Inc.
|
323,733 | $41,599,690 | |
| 6 | NVS |
Novartis AG
|
185,906 | $29,135,188 | |
| 7 | AMGN |
Amgen Inc
|
79,199 | $28,679,541 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
229,499 | $13,223,732 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,968,548 | 102,648 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $13,666,761 | 98,061 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $11,679,201 | 95,154 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,507,930 | 58,630 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,158,495 | 55,547 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $8,409,464 | 75,051 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,002,382 | 86,634 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,381,649 | 76,117 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,462,170 | 94,187 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,481,435 | 61,180 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,444,532 | 54,864 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,586,403 | 47,857 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,039,640 | 39,440 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,504,486 | 42,238 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,168,389 | 83,499 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $4,574,992 | 74,161 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $4,176,872 | 67,576 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,036,824 | 51,082 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $5,490,187 | 75,612 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $5,130,552 | 73,451 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $3,781,033 | 54,909 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $3,464,103 | 53,599 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $3,037,618 | 52,139 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $2,803,677 | 44,369 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||